Klaus Klumpp

Also affiliated with Richmond Chemical (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19”.

Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.20.440676

N/A

0DataRank · unranked

24 citations

Jian Zheng, Kevin Wilhelmsen, Kun Li, Miguel Ortiz, Nicholas Schnicker +12 more

Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19

Nature(2022)10.1038/s41586-022-04630-3

N/A

0DataRank · unranked

190 citations

Jian Zheng, Kevin Wilhelmsen, Kun Li, Miguel Ortiz, Nicholas Schnicker +18 more

The prostaglandin D2 antagonist asapiprant ameliorates clinical severity in young hosts infected with invasive Streptococcus pneumoniae

Infection and Immunity(2024)10.1128/iai.00522-23

N/A

0DataRank · unranked

1 citations

Sydney E. Herring, Alexsandra P. Lenhard, Joshua Wheeler, Fred Aswad, Klaus Klumpp +6 more

CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection

Journal of Clinical Investigation(2025)10.1172/jci188222

N/A

0DataRank · unranked

8 citations

Hima Dhakal, Enya Qing, Rejeena Shrestha, Anne E. Geller, Samantha M. Morrissey +21 more